Reports

Industry Research Reports

Global Lentiviral Vector Production System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Lentiviral Vector Production System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Care

Published Date: 2026-05-29

Pages: 174 Pages

Report ld: 6717534

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Lentiviral Vector Production System Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

11.3%

marketSize

Market Size,2032

USD 2,623

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 1,384 million
Market Forecast in 2032(Value)
US$ 2,623 million
CAGR
11.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Lentiviral Vector Production System market size was US$ 1252 million in 2025 and is forecast to reach a readjusted size of US$ 2623 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.

Lentiviral Vector Production System refers to an integrated set of cell culture, transfection or producer cell line, vector plasmid, packaging, envelope, harvest, purification and quality control processes used to generate lentiviral vector particles for gene delivery, cell therapy, gene therapy research and biomanufacturing applications. The system typically relies on producer cells, commonly HEK293 or HEK293T derived cells, that supply the necessary viral packaging functions while carrying the target genetic payload in a transfer vector, enabling production of replication deficient lentiviral particles that can efficiently deliver genetic material into target cells.

The Lentiviral Vector Production System market is shifting from research-scale vector preparation toward clinical-grade and commercial manufacturing. Demand is mainly driven by cell therapy, gene therapy and functional genomics applications. As gene-modified cell therapy programs continue to advance, customers increasingly require high-titer, high-purity, low-residual, scalable and GMP-compliant production systems. This is driving the market from standalone transfection or packaging reagents toward end-to-end process platforms covering cell culture, plasmid supply, viral packaging, harvest and clarification, purification and concentration, and quality control. Future competition will focus on production efficiency, batch-to-batch consistency, closed and automated processing, regulatory compliance, and process transferability from research-grade to clinical-grade manufacturing.

The global Lentiviral Vector Production System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Lonza
  • Charles River
  • Merck
  • Cytiva
  • OXB
  • AGC Biologics
  • OriGene
  • Sartorius
  • OmniaBio
  • SignaGen Laboratories
  • Cellomics Technology
  • Miltenyi Bioindustry
  • Gene Universal
  • Takara Bio
  • Gentarget
  • Genezen
  • Creative Biogene
  • VIVEbiotech
  • SK pharmteco
  • Esco Aster
  • Andelyn Biosciences
  • GENEWIZ
  • GenScript ProBio
  • VectorBuilder
  • OBiO Tech
  • GenePharma
  • GeneMedi
  • Genevoyager
  • FulenGen

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Production Workflow Products
  • GMP Manufacturing Services
  • Research-grade Packaging Services

Segment by Application

  • Cell Therapy
  • Gene Therapy
  • Basic Research
  • Others

Segment by Category

  • Transient Transfection
  • Stable Cell Line

Segment by Division

  • Adherent Production
  • Suspension Production

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

Table of Contents

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Production Workflow Products

1.2.3 GMP Manufacturing Services

1.2.4 Research-grade Packaging Services

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Cell Therapy

1.3.3 Gene Therapy

1.3.4 Basic Research

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Lentiviral Vector Production System Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Lentiviral Vector Production System Market Share by Revenue, by Region (2021-2026)

2.4 Global Lentiviral Vector Production System Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Lentiviral Vector Production System Market Size and Prospective (2021-2032)

2.5.2 Europe Lentiviral Vector Production System Market Size and Prospective (2021-2032)

2.5.3 China Lentiviral Vector Production System Market Size and Prospective (2021-2032)

2.5.4 Japan Lentiviral Vector Production System Market Size and Prospective (2021-2032)

muLu

3 Breakdown Data by Type

3.1 Global Lentiviral Vector Production System Historical Market Size by Type (2021-2026)

3.2 Global Lentiviral Vector Production System Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Lentiviral Vector Production System

muLu

4 Breakdown Data by Application

4.1 Global Lentiviral Vector Production System Historical Market Size by Application (2021-2026)

4.2 Global Lentiviral Vector Production System Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Lentiviral Vector Production System Applications

muLu

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Lentiviral Vector Production System Players by Revenue (2021-2026)

5.1.2 Global Lentiviral Vector Production System Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Lentiviral Vector Production System Revenue

5.4 Global Lentiviral Vector Production System Market Concentration Analysis

5.4.1 Global Lentiviral Vector Production System Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Lentiviral Vector Production System Revenue in 2025

5.5 Global Key Players of Lentiviral Vector Production System Head Offices and Areas Served

5.6 Global Key Players of Lentiviral Vector Production System, Product and Application

5.7 Global Key Players of Lentiviral Vector Production System, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Lentiviral Vector Production System Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Lentiviral Vector Production System Market Size by Type (2021-2026)

6.1.2.2 North America Lentiviral Vector Production System Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Lentiviral Vector Production System Market Size by Application (2021-2026)

6.1.3.2 North America Lentiviral Vector Production System Market Share by Application (2021-2026)

6.1.4 North America Lentiviral Vector Production System Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Lentiviral Vector Production System Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Lentiviral Vector Production System Market Size by Type (2021-2026)

6.2.2.2 Europe Lentiviral Vector Production System Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Lentiviral Vector Production System Market Size by Application (2021-2026)

6.2.3.2 Europe Lentiviral Vector Production System Market Share by Application (2021-2026)

6.2.4 Europe Lentiviral Vector Production System Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Lentiviral Vector Production System Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Lentiviral Vector Production System Market Size by Type (2021-2026)

6.3.2.2 China Lentiviral Vector Production System Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Lentiviral Vector Production System Market Size by Application (2021-2026)

6.3.3.2 China Lentiviral Vector Production System Market Share by Application (2021-2026)

6.3.4 China Lentiviral Vector Production System Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Lentiviral Vector Production System Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Lentiviral Vector Production System Market Size by Type (2021-2026)

6.4.2.2 Japan Lentiviral Vector Production System Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Lentiviral Vector Production System Market Size by Application (2021-2026)

6.4.3.2 Japan Lentiviral Vector Production System Market Share by Application (2021-2026)

6.4.4 Japan Lentiviral Vector Production System Major Customers

6.4.5 Japan Market Trends and Opportunities

muLu

7 Key Player Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Company Details

7.1.2 Thermo Fisher Scientific Business Overview

7.1.3 Thermo Fisher Scientific Lentiviral Vector Production System Introduction

7.1.4 Thermo Fisher Scientific Revenue in Lentiviral Vector Production System Business (2021-2026)

7.1.5 Thermo Fisher Scientific Recent Development

7.2 Lonza

7.2.1 Lonza Company Details

7.2.2 Lonza Business Overview

7.2.3 Lonza Lentiviral Vector Production System Introduction

7.2.4 Lonza Revenue in Lentiviral Vector Production System Business (2021-2026)

7.2.5 Lonza Recent Development

7.3 Charles River

7.3.1 Charles River Company Details

7.3.2 Charles River Business Overview

7.3.3 Charles River Lentiviral Vector Production System Introduction

7.3.4 Charles River Revenue in Lentiviral Vector Production System Business (2021-2026)

7.3.5 Charles River Recent Development

7.4 Merck

7.4.1 Merck Company Details

7.4.2 Merck Business Overview

7.4.3 Merck Lentiviral Vector Production System Introduction

7.4.4 Merck Revenue in Lentiviral Vector Production System Business (2021-2026)

7.4.5 Merck Recent Development

7.5 Cytiva

7.5.1 Cytiva Company Details

7.5.2 Cytiva Business Overview

7.5.3 Cytiva Lentiviral Vector Production System Introduction

7.5.4 Cytiva Revenue in Lentiviral Vector Production System Business (2021-2026)

7.5.5 Cytiva Recent Development

7.6 OXB

7.6.1 OXB Company Details

7.6.2 OXB Business Overview

7.6.3 OXB Lentiviral Vector Production System Introduction

7.6.4 OXB Revenue in Lentiviral Vector Production System Business (2021-2026)

7.6.5 OXB Recent Development

7.7 AGC Biologics

7.7.1 AGC Biologics Company Details

7.7.2 AGC Biologics Business Overview

7.7.3 AGC Biologics Lentiviral Vector Production System Introduction

7.7.4 AGC Biologics Revenue in Lentiviral Vector Production System Business (2021-2026)

7.7.5 AGC Biologics Recent Development

7.8 OriGene

7.8.1 OriGene Company Details

7.8.2 OriGene Business Overview

7.8.3 OriGene Lentiviral Vector Production System Introduction

7.8.4 OriGene Revenue in Lentiviral Vector Production System Business (2021-2026)

7.8.5 OriGene Recent Development

7.9 Sartorius

7.9.1 Sartorius Company Details

7.9.2 Sartorius Business Overview

7.9.3 Sartorius Lentiviral Vector Production System Introduction

7.9.4 Sartorius Revenue in Lentiviral Vector Production System Business (2021-2026)

7.9.5 Sartorius Recent Development

7.10 OmniaBio

7.10.1 OmniaBio Company Details

7.10.2 OmniaBio Business Overview

7.10.3 OmniaBio Lentiviral Vector Production System Introduction

7.10.4 OmniaBio Revenue in Lentiviral Vector Production System Business (2021-2026)

7.10.5 OmniaBio Recent Development

7.11 SignaGen Laboratories

7.11.1 SignaGen Laboratories Company Details

7.11.2 SignaGen Laboratories Business Overview

7.11.3 SignaGen Laboratories Lentiviral Vector Production System Introduction

7.11.4 SignaGen Laboratories Revenue in Lentiviral Vector Production System Business (2021-2026)

7.11.5 SignaGen Laboratories Recent Development

7.12 Cellomics Technology

7.12.1 Cellomics Technology Company Details

7.12.2 Cellomics Technology Business Overview

7.12.3 Cellomics Technology Lentiviral Vector Production System Introduction

7.12.4 Cellomics Technology Revenue in Lentiviral Vector Production System Business (2021-2026)

7.12.5 Cellomics Technology Recent Development

7.13 Miltenyi Bioindustry

7.13.1 Miltenyi Bioindustry Company Details

7.13.2 Miltenyi Bioindustry Business Overview

7.13.3 Miltenyi Bioindustry Lentiviral Vector Production System Introduction

7.13.4 Miltenyi Bioindustry Revenue in Lentiviral Vector Production System Business (2021-2026)

7.13.5 Miltenyi Bioindustry Recent Development

7.14 Gene Universal

7.14.1 Gene Universal Company Details

7.14.2 Gene Universal Business Overview

7.14.3 Gene Universal Lentiviral Vector Production System Introduction

7.14.4 Gene Universal Revenue in Lentiviral Vector Production System Business (2021-2026)

7.14.5 Gene Universal Recent Development

7.15 Takara Bio

7.15.1 Takara Bio Company Details

7.15.2 Takara Bio Business Overview

7.15.3 Takara Bio Lentiviral Vector Production System Introduction

7.15.4 Takara Bio Revenue in Lentiviral Vector Production System Business (2021-2026)

7.15.5 Takara Bio Recent Development

7.16 Gentarget

7.16.1 Gentarget Company Details

7.16.2 Gentarget Business Overview

7.16.3 Gentarget Lentiviral Vector Production System Introduction

7.16.4 Gentarget Revenue in Lentiviral Vector Production System Business (2021-2026)

7.16.5 Gentarget Recent Development

7.17 Genezen

7.17.1 Genezen Company Details

7.17.2 Genezen Business Overview

7.17.3 Genezen Lentiviral Vector Production System Introduction

7.17.4 Genezen Revenue in Lentiviral Vector Production System Business (2021-2026)

7.17.5 Genezen Recent Development

7.18 Creative Biogene

7.18.1 Creative Biogene Company Details

7.18.2 Creative Biogene Business Overview

7.18.3 Creative Biogene Lentiviral Vector Production System Introduction

7.18.4 Creative Biogene Revenue in Lentiviral Vector Production System Business (2021-2026)

7.18.5 Creative Biogene Recent Development

7.19 VIVEbiotech

7.19.1 VIVEbiotech Company Details

7.19.2 VIVEbiotech Business Overview

7.19.3 VIVEbiotech Lentiviral Vector Production System Introduction

7.19.4 VIVEbiotech Revenue in Lentiviral Vector Production System Business (2021-2026)

7.19.5 VIVEbiotech Recent Development

7.20 SK pharmteco

7.20.1 SK pharmteco Company Details

7.20.2 SK pharmteco Business Overview

7.20.3 SK pharmteco Lentiviral Vector Production System Introduction

7.20.4 SK pharmteco Revenue in Lentiviral Vector Production System Business (2021-2026)

7.20.5 SK pharmteco Recent Development

7.21 Esco Aster

7.21.1 Esco Aster Company Details

7.21.2 Esco Aster Business Overview

7.21.3 Esco Aster Lentiviral Vector Production System Introduction

7.21.4 Esco Aster Revenue in Lentiviral Vector Production System Business (2021-2026)

7.21.5 Esco Aster Recent Development

7.22 Andelyn Biosciences

7.22.1 Andelyn Biosciences Company Details

7.22.2 Andelyn Biosciences Business Overview

7.22.3 Andelyn Biosciences Lentiviral Vector Production System Introduction

7.22.4 Andelyn Biosciences Revenue in Lentiviral Vector Production System Business (2021-2026)

7.22.5 Andelyn Biosciences Recent Development

7.23 GENEWIZ

7.23.1 GENEWIZ Company Details

7.23.2 GENEWIZ Business Overview

7.23.3 GENEWIZ Lentiviral Vector Production System Introduction

7.23.4 GENEWIZ Revenue in Lentiviral Vector Production System Business (2021-2026)

7.23.5 GENEWIZ Recent Development

7.24 GenScript ProBio

7.24.1 GenScript ProBio Company Details

7.24.2 GenScript ProBio Business Overview

7.24.3 GenScript ProBio Lentiviral Vector Production System Introduction

7.24.4 GenScript ProBio Revenue in Lentiviral Vector Production System Business (2021-2026)

7.24.5 GenScript ProBio Recent Development

7.25 VectorBuilder

7.25.1 VectorBuilder Company Details

7.25.2 VectorBuilder Business Overview

7.25.3 VectorBuilder Lentiviral Vector Production System Introduction

7.25.4 VectorBuilder Revenue in Lentiviral Vector Production System Business (2021-2026)

7.25.5 VectorBuilder Recent Development

7.26 OBiO Tech

7.26.1 OBiO Tech Company Details

7.26.2 OBiO Tech Business Overview

7.26.3 OBiO Tech Lentiviral Vector Production System Introduction

7.26.4 OBiO Tech Revenue in Lentiviral Vector Production System Business (2021-2026)

7.26.5 OBiO Tech Recent Development

7.27 GenePharma

7.27.1 GenePharma Company Details

7.27.2 GenePharma Business Overview

7.27.3 GenePharma Lentiviral Vector Production System Introduction

7.27.4 GenePharma Revenue in Lentiviral Vector Production System Business (2021-2026)

7.27.5 GenePharma Recent Development

7.28 GeneMedi

7.28.1 GeneMedi Company Details

7.28.2 GeneMedi Business Overview

7.28.3 GeneMedi Lentiviral Vector Production System Introduction

7.28.4 GeneMedi Revenue in Lentiviral Vector Production System Business (2021-2026)

7.28.5 GeneMedi Recent Development

7.29 Genevoyager

7.29.1 Genevoyager Company Details

7.29.2 Genevoyager Business Overview

7.29.3 Genevoyager Lentiviral Vector Production System Introduction

7.29.4 Genevoyager Revenue in Lentiviral Vector Production System Business (2021-2026)

7.29.5 Genevoyager Recent Development

7.30 FulenGen

7.30.1 FulenGen Company Details

7.30.2 FulenGen Business Overview

7.30.3 FulenGen Lentiviral Vector Production System Introduction

7.30.4 FulenGen Revenue in Lentiviral Vector Production System Business (2021-2026)

7.30.5 FulenGen Recent Development

muLu

8 Lentiviral Vector Production System Market Dynamics

8.1 Lentiviral Vector Production System Industry Trends

8.2 Lentiviral Vector Production System Market Drivers

8.3 Lentiviral Vector Production System Market Challenges

8.4 Lentiviral Vector Production System Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

Table of Figures

muLu

List of Tables

Table 1. Global Lentiviral Vector Production System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Lentiviral Vector Production System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Lentiviral Vector Production System Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Lentiviral Vector Production System Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Lentiviral Vector Production System Revenue Share by Region (2021-2026)
Table 6. Global Lentiviral Vector Production System Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Lentiviral Vector Production System Revenue Share Forecast by Region (2027-2032)
Table 8. Global Lentiviral Vector Production System Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Lentiviral Vector Production System Market Share by Revenue, by Type (2021-2026)
Table 10. Global Lentiviral Vector Production System Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Lentiviral Vector Production System Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Lentiviral Vector Production System Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Lentiviral Vector Production System Market Share by Revenue, by Application (2021-2026)
Table 15. Global Lentiviral Vector Production System Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Lentiviral Vector Production System Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Lentiviral Vector Production System Applications
Table 18. Global Lentiviral Vector Production System Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Lentiviral Vector Production System Market Share by Players (2021-2026)
Table 20. Global Top Lentiviral Vector Production System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lentiviral Vector Production System as of 2025)
Table 21. Ranking of Global Top Lentiviral Vector Production System Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Lentiviral Vector Production System Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Lentiviral Vector Production System, Headquarters and Area Served
Table 24. Global Key Players of Lentiviral Vector Production System, Product and Application
Table 25. Global Key Players of Lentiviral Vector Production System, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Lentiviral Vector Production System Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Lentiviral Vector Production System Market Share by Revenue, by Company (2021-2026)
Table 29. North America Lentiviral Vector Production System Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Lentiviral Vector Production System Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Lentiviral Vector Production System Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Lentiviral Vector Production System Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Lentiviral Vector Production System Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Lentiviral Vector Production System Market Size by Application (2021-2026) & (US$ Million)
Table 35. China Lentiviral Vector Production System Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Lentiviral Vector Production System Market Share by Revenue, by Company (2021-2026)
Table 37. China Lentiviral Vector Production System Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Lentiviral Vector Production System Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan Lentiviral Vector Production System Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan Lentiviral Vector Production System Market Share by Revenue, by Company (2021-2026)
Table 41. Japan Lentiviral Vector Production System Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan Lentiviral Vector Production System Market Size by Application (2021-2026) & (US$ Million)
Table 43. Thermo Fisher Scientific Company Details
Table 44. Thermo Fisher Scientific Business Overview
Table 45. Thermo Fisher Scientific Lentiviral Vector Production System Product
Table 46. Thermo Fisher Scientific Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 47. Thermo Fisher Scientific Recent Development
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Lentiviral Vector Production System Product
Table 51. Lonza Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Charles River Company Details
Table 54. Charles River Business Overview
Table 55. Charles River Lentiviral Vector Production System Product
Table 56. Charles River Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 57. Charles River Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Lentiviral Vector Production System Product
Table 61. Merck Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Cytiva Company Details
Table 64. Cytiva Business Overview
Table 65. Cytiva Lentiviral Vector Production System Product
Table 66. Cytiva Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 67. Cytiva Recent Development
Table 68. OXB Company Details
Table 69. OXB Business Overview
Table 70. OXB Lentiviral Vector Production System Product
Table 71. OXB Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 72. OXB Recent Development
Table 73. AGC Biologics Company Details
Table 74. AGC Biologics Business Overview
Table 75. AGC Biologics Lentiviral Vector Production System Product
Table 76. AGC Biologics Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 77. AGC Biologics Recent Development
Table 78. OriGene Company Details
Table 79. OriGene Business Overview
Table 80. OriGene Lentiviral Vector Production System Product
Table 81. OriGene Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 82. OriGene Recent Development
Table 83. Sartorius Company Details
Table 84. Sartorius Business Overview
Table 85. Sartorius Lentiviral Vector Production System Product
Table 86. Sartorius Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 87. Sartorius Recent Development
Table 88. OmniaBio Company Details
Table 89. OmniaBio Business Overview
Table 90. OmniaBio Lentiviral Vector Production System Product
Table 91. OmniaBio Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 92. OmniaBio Recent Development
Table 93. SignaGen Laboratories Company Details
Table 94. SignaGen Laboratories Business Overview
Table 95. SignaGen Laboratories Lentiviral Vector Production System Product
Table 96. SignaGen Laboratories Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 97. SignaGen Laboratories Recent Development
Table 98. Cellomics Technology Company Details
Table 99. Cellomics Technology Business Overview
Table 100. Cellomics Technology Lentiviral Vector Production System Product
Table 101. Cellomics Technology Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 102. Cellomics Technology Recent Development
Table 103. Miltenyi Bioindustry Company Details
Table 104. Miltenyi Bioindustry Business Overview
Table 105. Miltenyi Bioindustry Lentiviral Vector Production System Product
Table 106. Miltenyi Bioindustry Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 107. Miltenyi Bioindustry Recent Development
Table 108. Gene Universal Company Details
Table 109. Gene Universal Business Overview
Table 110. Gene Universal Lentiviral Vector Production System Product
Table 111. Gene Universal Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 112. Gene Universal Recent Development
Table 113. Takara Bio Company Details
Table 114. Takara Bio Business Overview
Table 115. Takara Bio Lentiviral Vector Production System Product
Table 116. Takara Bio Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 117. Takara Bio Recent Development
Table 118. Gentarget Company Details
Table 119. Gentarget Business Overview
Table 120. Gentarget Lentiviral Vector Production System Product
Table 121. Gentarget Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 122. Gentarget Recent Development
Table 123. Genezen Company Details
Table 124. Genezen Business Overview
Table 125. Genezen Lentiviral Vector Production System Product
Table 126. Genezen Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 127. Genezen Recent Development
Table 128. Creative Biogene Company Details
Table 129. Creative Biogene Business Overview
Table 130. Creative Biogene Lentiviral Vector Production System Product
Table 131. Creative Biogene Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 132. Creative Biogene Recent Development
Table 133. VIVEbiotech Company Details
Table 134. VIVEbiotech Business Overview
Table 135. VIVEbiotech Lentiviral Vector Production System Product
Table 136. VIVEbiotech Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 137. VIVEbiotech Recent Development
Table 138. SK pharmteco Company Details
Table 139. SK pharmteco Business Overview
Table 140. SK pharmteco Lentiviral Vector Production System Product
Table 141. SK pharmteco Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 142. SK pharmteco Recent Development
Table 143. Esco Aster Company Details
Table 144. Esco Aster Business Overview
Table 145. Esco Aster Lentiviral Vector Production System Product
Table 146. Esco Aster Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 147. Esco Aster Recent Development
Table 148. Andelyn Biosciences Company Details
Table 149. Andelyn Biosciences Business Overview
Table 150. Andelyn Biosciences Lentiviral Vector Production System Product
Table 151. Andelyn Biosciences Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 152. Andelyn Biosciences Recent Development
Table 153. GENEWIZ Company Details
Table 154. GENEWIZ Business Overview
Table 155. GENEWIZ Lentiviral Vector Production System Product
Table 156. GENEWIZ Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 157. GENEWIZ Recent Development
Table 158. GenScript ProBio Company Details
Table 159. GenScript ProBio Business Overview
Table 160. GenScript ProBio Lentiviral Vector Production System Product
Table 161. GenScript ProBio Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 162. GenScript ProBio Recent Development
Table 163. VectorBuilder Company Details
Table 164. VectorBuilder Business Overview
Table 165. VectorBuilder Lentiviral Vector Production System Product
Table 166. VectorBuilder Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 167. VectorBuilder Recent Development
Table 168. OBiO Tech Company Details
Table 169. OBiO Tech Business Overview
Table 170. OBiO Tech Lentiviral Vector Production System Product
Table 171. OBiO Tech Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 172. OBiO Tech Recent Development
Table 173. GenePharma Company Details
Table 174. GenePharma Business Overview
Table 175. GenePharma Lentiviral Vector Production System Product
Table 176. GenePharma Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 177. GenePharma Recent Development
Table 178. GeneMedi Company Details
Table 179. GeneMedi Business Overview
Table 180. GeneMedi Lentiviral Vector Production System Product
Table 181. GeneMedi Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 182. GeneMedi Recent Development
Table 183. Genevoyager Company Details
Table 184. Genevoyager Business Overview
Table 185. Genevoyager Lentiviral Vector Production System Product
Table 186. Genevoyager Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 187. Genevoyager Recent Development
Table 188. FulenGen Company Details
Table 189. FulenGen Business Overview
Table 190. FulenGen Lentiviral Vector Production System Product
Table 191. FulenGen Revenue in Lentiviral Vector Production System Business (2021-2026) & (US$ Million)
Table 192. FulenGen Recent Development
Table 193. Lentiviral Vector Production System Market Trends
Table 194. Lentiviral Vector Production System Market Drivers
Table 195. Lentiviral Vector Production System Market Challenges
Table 196. Lentiviral Vector Production System Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Lentiviral Vector Production System Product Picture
Figure 2. Global Lentiviral Vector Production System Market Share by Type: 2025 vs 2032
Figure 3. Production Workflow Products Features
Figure 4. GMP Manufacturing Services Features
Figure 5. Research-grade Packaging Services Features
Figure 6. Global Lentiviral Vector Production System Market Share by Application: 2025 vs 2032
Figure 7. Cell Therapy
Figure 8. Gene Therapy
Figure 9. Basic Research
Figure 10. Others
Figure 11. Lentiviral Vector Production System Report Years Considered
Figure 12. Global Lentiviral Vector Production System Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Lentiviral Vector Production System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Lentiviral Vector Production System Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Lentiviral Vector Production System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Lentiviral Vector Production System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. China Lentiviral Vector Production System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Japan Lentiviral Vector Production System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Lentiviral Vector Production System Market Share by Players in 2025
Figure 20. Global Top Lentiviral Vector Production System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lentiviral Vector Production System as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Lentiviral Vector Production System Revenue in 2025
Figure 22. North America Lentiviral Vector Production System Market Share by Type (2021-2026)
Figure 23. North America Lentiviral Vector Production System Market Share by Application (2021-2026)
Figure 24. Europe Lentiviral Vector Production System Market Share by Type (2021-2026)
Figure 25. Europe Lentiviral Vector Production System Market Share by Application (2021-2026)
Figure 26. China Lentiviral Vector Production System Market Share by Type (2021-2026)
Figure 27. China Lentiviral Vector Production System Market Share by Application (2021-2026)
Figure 28. Japan Lentiviral Vector Production System Market Share by Type (2021-2026)
Figure 29. Japan Lentiviral Vector Production System Market Share by Application (2021-2026)
Figure 30. Thermo Fisher Scientific Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 31. Lonza Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 32. Charles River Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 33. Merck Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 34. Cytiva Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 35. OXB Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 36. AGC Biologics Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 37. OriGene Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 38. Sartorius Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 39. OmniaBio Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 40. SignaGen Laboratories Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 41. Cellomics Technology Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 42. Miltenyi Bioindustry Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 43. Gene Universal Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 44. Takara Bio Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 45. Gentarget Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 46. Genezen Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 47. Creative Biogene Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 48. VIVEbiotech Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 49. SK pharmteco Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 50. Esco Aster Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 51. Andelyn Biosciences Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 52. GENEWIZ Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 53. GenScript ProBio Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 54. VectorBuilder Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 55. OBiO Tech Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 56. GenePharma Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 57. GeneMedi Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 58. Genevoyager Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 59. FulenGen Revenue Growth Rate in Lentiviral Vector Production System Business (2021-2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
den_biaoTiZhungShi

Related Reports

Global Lentiviral Vector Production System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Care

Published Date: 2026-05-29

Pages: 174 Pages

Report ld: 6717534

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English

English

Offline

HITESH

English

English

Offline

TANG XIN

Japanese

Japanese

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

Offline

DAMON

Chinese

Chinese

Offline

General Email:

REPORT COVERAGE

zhankai
den_ic7

Market Segmentation

den_ic7

QYResearch's Strengths

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

Interest In This Report?

Get A Free Sample

Pre-Order Enquiry

OR

Need a Tailored Report?

Customize this report to your needs.

Customize This Report

den_gou

Fact Checked

den_gou

Cite this Research

biaoTi

WORLD WIDE OFFICE